Navigation Links
New FORTEO® and EVISTA® Data to be Presented at Premiere Scientific Meeting for Bone and Mineral Research
Date:10/14/2010

INDIANAPOLIS, Oct. 14 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.

In partnership with TransPharma Medical Ltd., Lilly conducted a Phase II study and will present an oral poster session comparing efficacy, safety and teriparatide pharmacokinetics of teriparatide delivered transdermally and via SQ injection in a three-month, randomized, multicenter study in postmenopausal women with osteoporosis.

Of the nine additional studies involving teriparatide, eight investigated the effects of the treatment, with three also testing safety.  Additional notes about teriparatide or raloxifene studies to be presented include:

  • One study used data from the teriparatide Fracture Prevention Trial to study the effect of body composition on bone.
  • Another study compared baseline characteristics, persistence to therapy and reasons for discontinuation between the Puerto Rican population and mainland United States population enrolled in a large observational study of teriparatide.
  • Two studies will be presented that investigated the Osteoporosis Patient Assessment Questionnaire (OPAQ) and were conducted using the Multiple Outcomes of Raloxifene Evaluation (MORE) trial database.
  • One study used data to develop a modified version of OPAQ, while another study examined the relationship between a comprehensive measure of risk of fracture, based on FRAX®, and health-related quality of life as measured by OPAQ.

  • The presentations are scheduled:

  • Comparison of Transdermal and subcutaneous teripa
    '/>"/>

  • SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Frost & Sullivan Global Product Line Strategy of the Year Award Presented to Xenemetrix
    2. New Afatinib (BIBW 2992) Data in Non-Small Cell Lung Cancer Patients Presented at the 2010 ESMO Congress
    3. Amgen Highlights Key Clinical Data to be Presented at European Society for Medical Oncology Congress
    4. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
    5. Data from Multiple Clinical Trials of OrbusNeichs Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
    6. Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010
    7. Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C.
    8. Mayo Clinic Research on SurgiCount To Be Presented at Conferences
    9. 2010 Prix Galien USA Pro Bono Humanum Award to be Presented to UNITAID for Work In Global HIV/AIDS Effort
    10. Results From Investigator-Sponsored Trials Presented at SSIEM Conference
    11. Webcast Alert: Isis Pharmaceuticals Hosts Expert Panel Conference Call to Discuss Mipomersen Data Presented at the ESC Congress 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/16/2014)... 2014 Research and Markets has announced ... report to their offering. Animal vaccines ... Animal vaccines are generally prepared from weakened or dead microbes ... state. Some of the animal vaccines are also formulated using ... or toxic components. These components act as ...
    (Date:9/16/2014)... 16, 2014  Denovo Biopharma, LLC, today announced ... drug, from Eli Lilly and Company (NYSE:  LLY). ... commercialize enzastaurin globally, including transfer of all intellectual ... Lilly developed enzastaurin in a variety ... 3 clinical trials for diffuse large B-cell lymphoma ...
    (Date:9/16/2014)... Wash. , Sept. 16, 2014 /PRNewswire/ ... a late stage development company engaged primarily ... medical isotopes for diagnostic and therapeutic applications, ... for technology related to its brachytherapy products.  ... arise from its license from Battelle, under ...
    Breaking Medicine Technology:Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 2Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 3Advanced Medical Isotope Corporation Licensed Brachytherapy Seed Patent Granted 4
    ... 2011  GP Strategies Corporation (NYSE: GPX ), ... GP Strategies Corporation with and into its ... company structure. General Physics, which is the sole operating ... corporation and will be renamed GP Strategies Corporation when ...
    ... BOWIE, Md., Dec. 15, 2011  MedAssurant, Inc., ... today announced that Healthcare Partners, IPA (HCPIPA), ... associations (IPA) in the Northeast, has selected ... (CARA™)  solutions to proactively identify gaps in ...
    Cached Medicine Technology:GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 2GP Strategies Shareholders Approve Elimination of Holding Company Structure and Renaming of General Physics Corporation 3Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 2Healthcare Partners, IPA, Implements MedAssurant's Innovative, Data-Driven Solutions 3
    (Date:9/16/2014)... 16, 2014 Holganix, an elite member ... growing companies in the country, produces an organic Bionutritional ... health-care by naturally decreasing disease and insect damage though ... that it will hold its third annual Bionutritional Summit ... 22, 2014 from 1:00 P.M. through 6:00 P.M., the ...
    (Date:9/16/2014)... Recently, iFitDress.com, one of the most famous ... one shoulder evening gown collection. According to the company’s ... discounted rates (up to 69% off) at present. Additionally, all ... , “I am a frequent caller of your site. I ... dress, I feel quite happy. All items are of good ...
    (Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. 16, 2014 ... human papillomavirus (HPV), which is linked to the risk of ... that testing urine for HPV has good accuracy when compared ... lead researcher Dr. Neha Pathak. She is a resident in ... of London, England. The test could be done at ...
    (Date:9/16/2014)... These new programs allow those who haven’t owned a home ... in a 0% interest free, 2nd down payment assistance mortgage ... programs, are listed on their private website. The $10,000 does ... move out of the property. The down payment assistance 2nd ... monthly payments paid by the Borrower. The money is paid ...
    (Date:9/16/2014)... September 14, 2014 A new study ... branch (SB) stenting of true coronary bifurcation lesions ... care. The DKCRUSH-VI clinical trial is the first ... , Findings were reported today at the 26th ... by the Cardiovascular Research Foundation (CRF), TCT is ...
    Breaking Medicine News(10 mins):Health News:Holganix Holds 3rd Annual Bionutrional Summit in Louisville, Kentucky 2Health News:iFitDress.com: One Shoulder Evening Gown Collection Unveiled Online 2Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 2Health News:New Updated 2014 First Time Home Buyer Programs Available to Florida Residents 3Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2
    ... Justice Department,today announced that it has reached a ... headquartered in Southfield, Mich., under the,Americans with Disabilities ... Clinic refused to serve a prospective client because ... today,s agreement, Medical Weight Loss Clinic will,provide training ...
    ... more than 40 percent of widowers in that country whose ... they were either never told that their spouse,s cancer was ... of her life. Eighty-six percent of widowers believed next-of-kin should ... 71 percent of the men who did not recall being ...
    ... Preventive Medicine, (http://www.USPreventiveMedicine.com ) the leader in disease ... its campaign to make the,United States a healthier ... Pediatrics, which this week called for children to ... the "Healthiest Nation Campaign," a program aimed,at placing ...
    ... in Oxygen Orders, Lack of,Trained Technicians, ARLINGTON, ... program for durable medical equipment has created,concern and ... medical equipment providers across the country since it,was ... The bidding program has triggered widespread disruptions ...
    ... Chicago is one of 11 centers in the United ... Clinical Islet Transplant Consortium funded by the National Institutes ... to test new approaches to islet transplantation that may ... adults with difficult-to-control type 1 diabetes. , Patients with ...
    ... team will give the men we serve a distinct advantage on, ... ... Directors, DETROIT, July 8 The Mariners Inn shelter ... executive officer and David Sampson as chief operating officer., "Both Jim and ...
    Cached Medicine News:Health News:Justice Department Reaches Settlement Agreement With Medical Weight Loss Clinic 2Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:U.S. Preventive Medicine Applauds Leading Health Organizations for Disease Prevention Platforms 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:UIC in NIH-funded islet transplantation study for type 1 diabetes 2Health News:Mariners Inn Announces New Executive Leadership 2
    The GII titanium anchor with nitinol arcs is used for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor used by...
    ... greater definition than a standard Galilean ... The Hi-Res five element system provides ... lightweight system., ,Order frame separately., ,Keeler ... in a soft carrying case and ...
    The Nevyas Drape Support is the simple and inexpensive way to establish a zone of comfort for your patients during ophthalmic surgery which requires draping over the nose and mouth. Packaged in sets ...
    ... Wristrest has become an important standard in busy ... encircles the patient's head and supports arms and ... easy draping especially when fluids are collected. The ... way for easy patient transfer on and off ...
    Medicine Products: